India — Central Drugs Standard Control Organisation
Tracked across 16 events · 257 articles · First seen Mar 20, 2025 · Last active Aug 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: The India — Central Drugs Standard Control Organisation>>> approved Zayn Malik>>> for import and marketing in India, providing Wockhardt>>> with a domestic market for its new antibiotic.
May 29, 2026 · 9 articles
Regulatory
Impact: The CDSCO is the Indian regulatory body that granted the approval, enabling the expanded use of Wegovy for MASH.
Jul 17, 2026 · 13 articles
Regulatory
Impact: CDSCO granted approval for the new indication, enabling Emcure to offer Poviztra for MASH treatment.
Jul 20, 2026 · 8 articles
Regulatory
Impact: CDSCO, under the Ministry of Health, conducted the scientific evaluation and granted marketing authorization for QDENGA, enabling its introduction in India.
Jul 20, 2026 · 93 articles
Regulatory
Impact: India — Central Drugs Standard Control Organisation launched risk-based inspections of drugs across six states and is analyzing samples to determine the cause of deaths.
Oct 07, 2025 · 7 articles
Regulatory
Impact: The India — Central Drugs Standard Control Organisation is collaborating with state regulators in India to curb malpractices in the GLP-1 drug supply chain.
Mar 24, 2026 · 11 articles
Regulatory
Impact: The India — Central Drugs Standard Control Organisation is responsible for strengthening manufacturing processes and avoiding compliance failures within India's pharmaceutical sector, contributing to the new regulations.
Jun 16, 2026 · 22 articles
Business
Impact: The India — Central Drugs Standard Control Organisation provided marketing authorization for Tanstrive, enabling its launch in India and ensuring regulatory compliance for the new drug.
Jun 25, 2026 · 7 articles
Domestic
Impact: The India — Central Drugs Standard Control Organisation collaborated in the development of the Drug Registry, ensuring standardization of medicine data across India's healthcare system.
Jun 27, 2026 · 32 articles
Regulatory
Impact: The national drug regulatory authority that will implement the digital platform, enhancing its efficiency and transparency.
Jul 31, 2026 · 7 articles
Regulatory
Impact: CDSCO conducted the inspection and issued the order to discontinue sales; it is enforcing drug regulations.
Jul 07, 2026 · 17 articles
Accidents
Impact: The India — Central Drugs Standard Control Organisation has initiated risk-based inspections of drug manufacturing units across six states in response to the cough syrup tragedy, focusing on companies producing cough syrups, antipyretics, and antibiotics.
Oct 05, 2025 · 7 articles
Regulatory
Impact: The India — Central Drugs Standard Control Organisation alerted the India — Drugs Control Administration, Telangana, about the adulteration of Almont-Kid Syrup, playing a crucial role in identifying the issue.
Jan 10, 2026 · 6 articles
Business
Impact: CDSCO granted marketing authorisation for Leqembi, enabling its launch in India, reflecting its regulatory role.
Aug 03, 2026 · 6 articles
Regulatory
Impact: The India — Central Drugs Standard Control Organisation is involved as the draft notification for the amendments is available on its website for stakeholder comments.
Jun 28, 2026 · 6 articles
Tech
Impact: The India — Central Drugs Standard Control Organisation>>> has approved NaoTrac>>>, signifying its acceptance and quality for use in India.
May 26, 2026 · 6 articles
Bangladesh — Ministry of Health and Family Welfare
↔
India — Central Drugs Standard Control Organisation
Bangladesh — Ministry of Health and Family Welfare
↔
India — Central Drugs Standard Control Organisation
ERGEN INTELLIGENCE
Track India — Central Drugs Standard Control Organisation live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard